• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结肠癌细胞中过氧化物酶体增殖物激活受体γ的靶基因。

Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells.

作者信息

Gupta R A, Brockman J A, Sarraf P, Willson T M, DuBois R N

机构信息

Departments of Medicine and Cell Biology, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, Tennessee 37232, USA.

出版信息

J Biol Chem. 2001 Aug 10;276(32):29681-7. doi: 10.1074/jbc.M103779200. Epub 2001 Jun 7.

DOI:10.1074/jbc.M103779200
PMID:11397807
Abstract

Activation of the nuclear hormone peroxisome proliferator-activated receptor gamma (PPARgamma) inhibits cell growth and promotes differentiation in a broad spectrum of epithelial derived tumor cell lines. Here we utilized microarray technology to identify PPARgamma gene targets in intestinal epithelial cells. For each gene, the induction or repression was seen with two structurally distinct PPARgamma agonists, and the change in expression could be blocked by co-treatment with a specific PPARgamma antagonist. A majority of the genes could be regulated independently by a retinoid X receptor specific agonist. Genes implicated in lipid transport or storage (adipophilin and liver fatty acid-binding protein) were also activated by agonists of PPAR subtypes alpha and/or delta. In contrast, PPARgamma-selective targets included genes linked to growth regulatory pathways (regenerating gene IA), colon epithelial cell maturation (GOB-4 and keratin 20), and immune modulation (neutrophil-gelatinase-associated lipocalin). Additionally, three different genes of the carcinoembryonic antigen family were induced by PPARgamma. Cultured cells treated with PPARgamma ligands demonstrated an increase in Ca(2+)-independent, carcinoembryonic antigen-dependent homotypic aggregation, suggesting a potential role for PPARgamma in regulating intercellular adhesion. Collectively, these results will help define the mechanisms by which PPARgamma regulates intestinal epithelial cell biology.

摘要

核激素过氧化物酶体增殖物激活受体γ(PPARγ)的激活可抑制多种上皮来源肿瘤细胞系的细胞生长并促进其分化。在此,我们利用微阵列技术来鉴定肠上皮细胞中的PPARγ基因靶点。对于每个基因,两种结构不同的PPARγ激动剂均可诱导或抑制其表达,且与特异性PPARγ拮抗剂共同处理可阻断表达变化。大多数基因可由视黄酸X受体特异性激动剂独立调节。参与脂质转运或储存的基因(脂联素和肝脏脂肪酸结合蛋白)也可被PPARα和/或δ亚型的激动剂激活。相比之下,PPARγ选择性靶点包括与生长调节途径相关的基因(再生基因IA)、结肠上皮细胞成熟相关基因(GOB-4和角蛋白20)以及免疫调节相关基因(中性粒细胞明胶酶相关脂质运载蛋白)。此外,癌胚抗原家族的三个不同基因也可被PPARγ诱导。用PPARγ配体处理的培养细胞显示出非钙依赖性、癌胚抗原依赖性同型聚集增加,这表明PPARγ在调节细胞间黏附中可能发挥作用。总体而言,这些结果将有助于明确PPARγ调节肠上皮细胞生物学的机制。

相似文献

1
Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells.结肠癌细胞中过氧化物酶体增殖物激活受体γ的靶基因。
J Biol Chem. 2001 Aug 10;276(32):29681-7. doi: 10.1074/jbc.M103779200. Epub 2001 Jun 7.
2
Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22.过氧化物酶体增殖物激活受体γ和转化生长因子-β信号通路通过调节TSC-22的水平来抑制肠上皮细胞生长。
J Biol Chem. 2003 Feb 28;278(9):7431-8. doi: 10.1074/jbc.M208076200. Epub 2002 Dec 4.
3
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.过氧化物酶体增殖物激活受体γ(PPARγ)在人移行性膀胱癌中的表达及其在诱导细胞死亡中的作用。
Neoplasia. 1999 Oct;1(4):330-9. doi: 10.1038/sj.neo.7900050.
4
Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.过氧化物酶体增殖物激活受体γ在人涎腺癌细胞系中的表达及其合成配体的生长抑制作用
Int J Oncol. 2002 Mar;20(3):599-605.
5
A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.一种在天然启动子处分析核受体功能的新方法:使用分支DNA信使核糖核酸定量检测过氧化物酶体增殖物激活受体γ激动剂对aP2基因表达的作用。
Mol Endocrinol. 1999 Mar;13(3):410-7. doi: 10.1210/mend.13.3.0246.
6
Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators.过氧化物酶体增殖物激活受体γ和视黄酸X受体在募集核受体辅激活因子中的离散作用。
Mol Cell Biol. 2000 Nov;20(21):8008-17. doi: 10.1128/MCB.20.21.8008-8017.2000.
7
A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus.一种过氧化物酶体增殖物激活受体γ(PPARγ)突变体作为PPAR信号的显性负性抑制剂,定位于细胞核中。
Mol Cell Endocrinol. 2000 Apr 25;162(1-2):57-67. doi: 10.1016/s0303-7207(00)00211-2.
8
PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.过氧化物酶体增殖物激活受体γ激动剂可抑制ras转化的大鼠肠上皮细胞的细胞生长,并抑制细胞周期蛋白D1和表皮生长因子样生长因子的表达。
Int J Cancer. 2001 Nov 1;94(3):335-42. doi: 10.1002/ijc.1470.
9
Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.过氧化物酶体增殖物激活受体γ的激活通过干扰早期生长反应因子-1抑制白细胞介素-1β诱导的人滑膜成纤维细胞中膜相关前列腺素E2合酶-1的表达。
J Biol Chem. 2004 May 21;279(21):22057-65. doi: 10.1074/jbc.M402828200. Epub 2004 Mar 15.
10
Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms.过氧化物酶体增殖物激活受体γ介导的分化:结肠癌细胞中的一种突变揭示了不同的和细胞类型特异性机制。
J Biol Chem. 2003 Jun 20;278(25):22669-77. doi: 10.1074/jbc.M300637200. Epub 2003 Feb 18.

引用本文的文献

1
A Novel Peroxisome-Related Gene Signature Predicts Breast Cancer Prognosis and Correlates with T Cell Suppression.一种新型的过氧化物酶体相关基因特征可预测乳腺癌预后并与T细胞抑制相关。
Breast Cancer (Dove Med Press). 2024 Dec 9;16:887-911. doi: 10.2147/BCTT.S490154. eCollection 2024.
2
A novel peroxisome-related gene signature predicts clinical prognosis and is associated with immune microenvironment in low-grade glioma.一种新型过氧化物酶体相关基因特征可预测低级别胶质瘤的临床预后,并与免疫微环境相关。
PeerJ. 2024 Feb 20;12:e16874. doi: 10.7717/peerj.16874. eCollection 2024.
3
Delineating the role of nuclear receptors in colorectal cancer, a focused review.
阐述核受体在结直肠癌中的作用:一篇重点综述
Discov Oncol. 2024 Feb 19;15(1):41. doi: 10.1007/s12672-023-00808-x.
4
Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer.琥珀酸代谢:炎症、缺血/再灌注损伤和癌症的一个有前景的治疗靶点。
Front Cell Dev Biol. 2023 Sep 22;11:1266973. doi: 10.3389/fcell.2023.1266973. eCollection 2023.
5
Nuclear hormone receptors in demyelinating diseases.脱髓鞘疾病中的核激素受体。
J Neuroendocrinol. 2022 Jul;34(7):e13171. doi: 10.1111/jne.13171. Epub 2022 Jun 22.
6
Cornelian Cherry ( L.) Iridoid and Anthocyanin Extract Enhances PPAR-α, PPAR-γ Expression and Reduces I/M Ratio in Aorta, Increases LXR-α Expression and Alters Adipokines and Triglycerides Levels in Cholesterol-Rich Diet Rabbit Model.Cornelian Cherry ( L.) 鸢尾苷和花色苷提取物可增强 PPAR-α、PPAR-γ 的表达,降低主动脉的 I/M 比值,增加 LXR-α 的表达,并改变富含胆固醇饮食兔模型中的脂肪因子和甘油三酯水平。
Nutrients. 2021 Oct 16;13(10):3621. doi: 10.3390/nu13103621.
7
Mechanistic understanding of β-cryptoxanthin and lycopene in cancer prevention in animal models.β-隐黄质和番茄红素在动物模型中预防癌症的作用机制研究。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Nov;1865(11):158652. doi: 10.1016/j.bbalip.2020.158652. Epub 2020 Feb 5.
8
Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.PPAR 调节剂在健康与疾病中的探索与开发:临床证据的更新。
Int J Mol Sci. 2019 Oct 11;20(20):5055. doi: 10.3390/ijms20205055.
9
Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells.肠道细胞中 Wnt/β-catenin/PPARγ 通路对酮体生成酶 HMGCS2 的调控作用。
Cells. 2019 Sep 19;8(9):1106. doi: 10.3390/cells8091106.
10
Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer.姜黄素诱导结直肠癌细胞凋亡的机制。
Int J Mol Sci. 2019 May 17;20(10):2454. doi: 10.3390/ijms20102454.